This looks like a sure thing for short sellers, but that acquisition risk creates significant doubt. As the saying goes, “If you aren’t sure, don’t do it”, but it could still present some nice selling opportunities intraday nonetheless.
Holding overnight would be playing a risky game unless you can ascertain from more in-depth research that this “strategic alternatives” story is just a ploy.
Blackrock reduced their position below 5% on June 30, 2019
Algovita 2019 revenue guidance revised to $50-55 million, previously $57-62 million.